Growth • Spruce Biosciences
SPRB
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The pipeline products of the company include Tralesinidase Alfa (TA-ERT), and Tildacerfont/ Cortibon, a Companion Diagnostic, developed in partnership with HMNC Brain Health.
-4,2%
CAGR Op. Income 5Y
Operating Income Compound Annual Growth Rate in the last 5 years.
-4,5%
CAGR Net Income 5Y
Net Income Compound Annual Growth Rate in the last 5 years.
-23,1%
CAGR EPS 5Y
Earnings Per Share Compound Annual Growth Rate in the last 5 years.
-3,9%
CAGR OCF 5Y
Cash Flow from Operating activities Compound Annual Growth Rate in the last 5 years.
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!